
Many physicians may be joining other high-income taxpayers subject to an upcoming potentially large tax hike they may not even be aware of.

Many physicians may be joining other high-income taxpayers subject to an upcoming potentially large tax hike they may not even be aware of.

To meet the challenges of a changing specialty, urologists across the country have organized into large, comprehensive integrated practices, often including physicians from other specialties, to deliver the highest quality care and service to patients with urologic diseases and conditions.

It is always recommended that, in addition to the clinical circumstances that caused the increased work, you include a relative time reference to justify the additional fee.

PSA kinetics can be used to identify patients with nonmetastatic castration-resistant prostate cancer (CRPC) who are at enhanced risk for bone metastases or death.

Recent studies from around the world provide encouraging evidence of the safety of high-intensity focused ultrasound (HIFU) as a minimally invasive treatment for localized prostate cancer.

A retrospective long-term comparison of three prostate cancer treatment strategies revealed that treatment with external beam radiation therapy (EBRT) resulted in more long-term toxicities and higher treatment-related costs than prostatectomy and brachytherapy.

HIFU continues to represent a promising minimally invasive approach for many men with prostate cancer. What its exact role will become remains unclear.

Active surveillance appears to be a safe option for carefully selected patients diagnosed with prostate cancer. However, changes in biopsy scheduling and technique may be needed to detect high-grade cases.

A recent study may have found the genetic mechanism behind the potential association between vigorous exercise and a reduced risk of prostate cancer progression and prostate cancer-specific mortality in men with localized disease.

A comparative effectiveness analysis of three techniques for delivering radiation therapy for the treatment of localized prostate cancer supports intensity-modulated radiation therapy (IMRT) as the current standard.

As the stopping point for the upcoming AUA 2012 annual meeting, May 19-23, Atlanta is sure to impress with its range of simple to sophisticated offerings in the arts, entertainment, culinary, and historical scenes.

Forging and leveraging relationships with state legislators and their staff can help you protect your patients, employees, and practice from harmful legislation.


Compared with women who deliver via cesarean, women who deliver vaginally are 67% more likely to experience urinary incontinence up to 20 years after the birth and are almost three times as likely to be incontinent for more than 10 years, Swedish researchers report.

Pelvic floor muscle training is effective for treating adult women with urinary incontinence without risk of side effects, according to a recent report.

The FDA has announced changes to the professional labels for finasteride, 5 mg (Proscar), and finasteride, 1 mg (Propecia), to expand the list of sexual adverse events reported to the FDA, as some of these events have been reported to continue after the drug is no longer being used.

Compared with conformal radiation therapy, intensity-modulated radiation therapy (IMRT) was associated with fewer diagnoses of gastrointestinal adverse effects, hip fractures, and receipt of additional cancer treatments but more cases of erectile dysfunction in an analysis of three different types of radiation therapy used to treat localized prostate cancer.

For the second time in a month, urologists are being criticized for self-referred ancillary services?this time by radiologists for providing intensity-modulated radiotherapy (IMRT) treatment for prostate cancer patients in urologists' own radiation therapy centers.

Urologists' self-referral of prostate surgical pathology services leads to increased use and higher Medicare spending but lower cancer detection rates, according to a recent study.

Venkata R. Jayanthi, MD, has been appointed chief of the section of pediatric urology at Nationwide Children's Hospital, Columbus, OH.

When parents say their child's urine smells bad, physicians should test for a urinary tract infection, Canadian researchers report.

Patients taking oral fluoroquinolones had a higher risk of developing a retinal detachment compared with nonusers, although the absolute risk was small, according to a recent study.

The FDA's Reproductive Health Drugs Advisory Committee recently voted that the overall risk/benefit assessment supports approval of the investigational agent mirabegron for the treatment of overactive bladder.

An international research team led by investigators from Weill Cornell Medical College, New York has discovered two inherited-genetic deletions in the human genome linked to the development of aggressive prostate cancer.

The AUA Foundation announced that Astellas U.S. has awarded a $1.2 million independent educational grant to continue its support of young academic urologists through the AUA Foundation/Astellas Rising Stars in Urology Award program.

Prostatic artery embolization may be an effective treatment for men suffering from symptoms of an enlarged prostate, researchers said at the Society of Interventional Radiology annual scientific meeting in San Francisco.

Kidney stones in fruit flies may hold the key to developing a treatment that could stop the formation of stones in humans, according to a research team from Mayo Clinic and the University of Glasgow.

A class I histone deacetylase inhibitor, entinostat, has been shown to boost the effectiveness of cancer immunotherapy for treatment of some solid tumors, including kidney and prostate cancer, according to preclinical research by a team from Roswell Park Cancer Institute.

Saying the sustainable growth rate system is fundamentally flawed and has helped erode the confidence of Medicare beneficiaries and physicians alike, the Medicare Payment Advisory Commission is again asking Congress to repeal the SGR and replace it with specified updates no longer based on an expenditure-control formula, as recommended by MedPAC last year.

Effective advocacy depends on data, relationships, and, for lack of a better term, money.